{
    "2019-04-26": [
        [
            {
                "time": "2018-12-31",
                "original_text": "沃森生物：2018年度计提资产减值1.17亿 资产异常",
                "features": {
                    "keywords": [
                        "计提资产减值",
                        "资产异常",
                        "沃森生物"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2019-03-31",
                "original_text": "沃森生物(300142.SZ)一季度净利润升68.80%至4010.39万元",
                "features": {
                    "keywords": [
                        "一季度",
                        "净利润增长",
                        "沃森生物"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-12-31",
                "original_text": "沃森生物(300142.SZ)2018年扭亏为盈至10.46亿元 拟10派0.3元",
                "features": {
                    "keywords": [
                        "扭亏为盈",
                        "分红",
                        "沃森生物"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-05-15",
                "original_text": "[快讯]沃森生物:调整部分募集资金投资项目达到预定可使用状态时间",
                "features": {
                    "keywords": [
                        "调整项目",
                        "募集资金",
                        "沃森生物"
                    ],
                    "sentiment_score": -0.3,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-12-31",
                "original_text": "沃森生物：2018年业绩同比扭亏净利润为10.46亿元",
                "features": {
                    "keywords": [
                        "扭亏为盈",
                        "净利润",
                        "沃森生物"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-03-31",
                "original_text": "沃森生物：一季度净利润同比增68.80%",
                "features": {
                    "keywords": [
                        "一季度",
                        "净利润增长",
                        "沃森生物"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}